Oddo BHF upgraded Philips to Outperform from Neutral with a EUR 40 price target The firm says it is “time to look forward” and ignore the “noise” from the sleep apnea recall.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Philips upgraded to Outperform from Neutral at Oddo BHF
- Philips, Siloam Hospitals Group sign AI capability MoU
- Philips price target raised to EUR 28.50 from EUR 26.50 at Citi
- Philips, Jackson Health System announces results of collaborative LCA
- Philips announces FDA approval for enhance LumiGuide guidewire